Home/Fountain Therapeutics/Joseph T Rodgers, Ph.D.
JT

Joseph T Rodgers, Ph.D.

Co-Founder, Scientific and Technical Lead

Fountain Therapeutics

Fountain Therapeutics Pipeline

DrugIndicationPhase
FTX002600/FTX003059 Topical CombinationSkin Atrophy (age- and weight loss-associated)Preclinical
FTX008762Sarcopenia and GLP-1 agonist-induced lean tissue atrophyPreclinical